Home/Filings/4/0000899243-23-002075
4//SEC Filing

Katz Barrett 4

Accession 0000899243-23-002075

CIK 0001590750other

Filed

Jan 17, 7:00 PM ET

Accepted

Jan 18, 5:58 PM ET

Size

15.1 KB

Accession

0000899243-23-002075

Insider Transaction Report

Form 4
Period: 2023-01-13
Katz Barrett
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-01-1724,853267,000 total
    Exercise: $23.03Exp: 2031-01-17Common Stock (24,853 underlying)
  • Exercise/Conversion

    Common Stock

    2023-01-13$23.03/sh+4,147$95,5054,147 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-01-134,147291,853 total
    Exercise: $23.03Exp: 2031-01-17Common Stock (4,147 underlying)
  • Sale

    Common Stock

    2023-01-13$37.01/sh4,147$153,4800 total
  • Sale

    Common Stock

    2023-01-17$37.21/sh24,853$924,7800 total
  • Exercise/Conversion

    Common Stock

    2023-01-17$23.03/sh+24,853$572,36524,853 total
Footnotes (3)
  • [F1]This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $37.00 to $37.05. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $37.00 to $37.58. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]The option vested 25% on January 18, 2022 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date.

Issuer

Viridian Therapeutics, Inc.\DE

CIK 0001590750

Entity typeother

Related Parties

1
  • filerCIK 0001841628

Filing Metadata

Form type
4
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 5:58 PM ET
Size
15.1 KB